MorphoSys Announces Acquisition of Sloning
Combination of Technologies Set to Increase Success Rates in Drug Development
11-Oct-2010 -
MorphoSys AG announced the acquisition of Sloning BioTechnology GmbH. The transaction will make MorphoSys the sole source of Sloning's state-of-the-art Slonomics technology, which improves the assembly and quality of protein libraries. By integrating Slonomics into its existing antibody ...
amino acids
antibodies
collaborations
+4